Matthew J During
Matthew J During
Emrys Bio
Verified email at
Cited by
Cited by
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
MG Kaplitt, P Leone, RJ Samulski, X Xiao, DW Pfaff, KL O'Malley, ...
Nature genetics 8 (2), 148-154, 1994
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in …
M Nauck, A Frid, K Hermansen, NS Shah, T Tankova, IH Mitha, ...
Diabetes care 32 (1), 84-90, 2009
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
MG Kaplitt, A Feigin, C Tang, HL Fitzsimons, P Mattis, PA Lawlor, ...
The Lancet 369 (9579), 2097-2105, 2007
Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain
MJ During, DD Spencer
The lancet 341 (8861), 1607-1610, 1993
VEGF links hippocampal activity with neurogenesis, learning and memory
L Cao, X Jiao, DS Zuzga, Y Liu, DM Fong, D Young, MJ During
Nature genetics 36 (8), 827-835, 2004
Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective
D Young, PA Lawlor, P Leone, M Dragunow, MJ During
Nature medicine 5 (4), 448-453, 1999
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
MJ During, L Cao, DS Zuzga, JS Francis, HL Fitzsimons, X Jiao, RJ Bland, ...
Nature medicine 9 (9), 1173-1179, 2003
Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial
RE MacLaren, M Groppe, AR Barnard, CL Cottriall, T Tolmachova, ...
The Lancet 383 (9923), 1129-1137, 2014
The endocannabinoid system controls key epileptogenic circuits in the hippocampus
K Monory, F Massa, M Egertová, M Eder, H Blaudzun, R Westenbroek, ...
Neuron 51 (4), 455-466, 2006
Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach
W Lu, Y Shi, AC Jackson, K Bjorgan, MJ During, R Sprengel, PH Seeburg, ...
Neuron 62 (2), 254-268, 2009
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
PA LeWitt, AR Rezai, MA Leehey, SG Ojemann, AW Flaherty, ...
The Lancet Neurology 10 (4), 309-319, 2011
Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1
H Johnen, S Lin, T Kuffner, DA Brown, VWW Tsai, AR Bauskin, L Wu, ...
Nature medicine 13 (11), 1333-1340, 2007
Adenosine: a potential mediator of seizure arrest and postictal refractoriness
MJ During, DD Spencer
Annals of neurology 32 (5), 618-624, 1992
Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase
MJ During, JR Naegele, KL O'Malley, AI Geller
Science 266 (5189), 1399-1403, 1994
Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release
WP Borg, RS Sherwin, MJ During, MA Borg, GI Shulman
Diabetes 44 (2), 180-184, 1995
White to brown fat phenotypic switch induced by genetic and environmental activation of a hypothalamic-adipocyte axis
L Cao, EY Choi, X Liu, A Martin, C Wang, X Xu, MJ During
Cell metabolism 14 (3), 324-338, 2011
Hippocampal GABA transporter function in temporal-lobe epilepsy
MJ During, KM Ryder, DD Spencer
Nature 376 (6536), 174-177, 1995
Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition
L Cao, X Liu, EJD Lin, C Wang, EY Choi, V Riban, B Lin, MJ During
Cell 142 (1), 52-64, 2010
Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy
O Akil, RP Seal, K Burke, C Wang, A Alemi, M During, RH Edwards, ...
Neuron 75 (2), 283-293, 2012
Subthalamic GAD gene therapy in a Parkinson's disease rat model
J Luo, MG Kaplitt, HL Fitzsimons, DS Zuzga, Y Liu, ML Oshinsky, ...
Science 298 (5592), 425-429, 2002
The system can't perform the operation now. Try again later.
Articles 1–20